Chemical Modification of Proteins by Lipids in Diabetes
- 16 January 2003
- journal article
- review article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 41 (9) , 1159-1165
- https://doi.org/10.1515/cclm.2003.179
Abstract
Advanced glycation and lipoxidation endproducts (AGE/ALE) increase in tissue proteins with age and at an accelerated rate in diabetes. This Review focuses on the nature and source of AGEs/ALEs and the factors affecting their formation in tissue and plasma proteins. Lipids are identified as an important source of chemical modification of proteins in diabetes, and the role of diabetes, dyslipidemia and renal disease in formation of AGEs/ALEs is reviewed. The article concludes with a discussion of ELISA assays for AGEs/ALEs and the merits of measuring AGEs/ALEs in the clinical laboratory.Keywords
This publication has 43 references indexed in Scilit:
- The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese ratsKidney International, 2003
- Restriction of Dietary Glycotoxins Reduces Excessive Advanced Glycation End Products in Renal Failure PatientsJournal of the American Society of Nephrology, 2003
- Pentosidine and Nε-(carboxymethyl)-lysine in Alzheimer’s disease and vascular dementiaNeurobiology of Aging, 2002
- Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic ratKidney International, 2002
- Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis – amelioration by liver transplantationJournal of Hepatology, 2002
- The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?Trends in Cardiovascular Medicine, 2001
- Reactive carbonyl compounds related uremic toxicity ("carbonyl stress")Kidney International, 2001
- Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia?Kidney International, 1998
- Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPDKidney International, 1994
- Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1991